Navigation Links
Cepheid to Webcast Upcoming Financial Presentations
Date:2/16/2011

SUNNYVALE, Calif., Feb. 16, 2011 /PRNewswire/ -- Cepheid (Nasdaq: CPHD) today announced that its executives will be speaking at the following investor conferences, and invited investors to participate via webcast.Citi Global Health Care Conference, New York, NYTuesday, March 1, 2011 at 8.30 a.m. Eastern TimeRBC Capital Markets' Healthcare Conference, New York, NYWednesday, March 2, 2011 at 11.00 a.m. Eastern TimeTo access the live webcasts for these events, please visit Cepheid's website at www.cepheid.com/investors at least 15 minutes before the scheduled start time to download any necessary audio or plug-in software.  A replay of the webcasts will be available shortly following the presentation and will remain available for at least 90 days.

About CepheidBased in Sunnyvale, Calif., Cepheid (Nasdaq: CPHD) is a leading molecular diagnostics company that is dedicated to improving healthcare by developing, manufacturing, and marketing accurate yet easy to use molecular systems and tests. By automating highly complex and time-consuming manual procedures, the company's solutions deliver a better way for institutions of any size to access the full power of molecular diagnostics. The company's systems enable rapid, sophisticated genetic testing for organisms and genetic-based diseases by automating otherwise complex manual laboratory procedures. Through its strong molecular biology capabilities, the company is focusing on those applications where accurate, rapid, and actionable test results are needed most, such as managing infectious diseases and cancer. For more information, visit www.cepheid.com.

CONTACTS:For Media Inquiries:For Investor Inquiries:Jared Tipton

Jacquie RossCepheid Corporate Communications

Cepheid Investor RelationsTel: (408) 400-8377

Tel: (408) 400-8329communications@cepheid.com

investor.relations@cepheid.com
'/>"/>

SOURCE Cepheid
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Cepheid Announces Termination of Contract With the Centers for Disease Control and Prevention to Develop Rapid Point of Care Test for Avian Influenza
2. Cepheid Launches New GeneXpert(R) Tests in Europe for Simultaneous, Rapid Detection of Staphylococcus Aureus and Methicillin Resistant Staphylococcus Aureus
3. Cepheid GeneXpert(R) System and Xpert(TM) MRSA Selected for up to 11 Victoria, Australia Hospitals in Rollout of Start Clean Strategy
4. Cepheid Announces CE IVD Release of First On-Demand Test for van A/van B Genes Most Associated With Hospital-Acquired VRE Infection
5. Cepheid Molecular Diagnostic Test for Positive Blood Culture Bottles Categorized Moderate Complexity by FDA
6. Cepheid Announces European Release of First On-Demand Molecular Test for Simultaneous Detection of Mycobacterium tuberculosis (TB) and Resistance to Rifampicin
7. Cepheid Receives Grant to Develop Ten-Color Real-Time PCR Detection Technology for Use in the GeneXpert(R) System
8. Cepheid Reports 2009 Third Quarter Results
9. Cepheid to Webcast Upcoming Financial Presentations
10. Cepheid Collaborates With Pharmaceutical Leader on Chronic Myelogenous Leukemia
11. Cepheid to Webcast Upcoming Financial Presentation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... 2017 Arthroscopy Devices Market Report, published by Allied Market Research, ... projected to reach $5,334 million by 2022, growing at a CAGR of 6.2% from ... in 2015. Continue Reading ... ...      (Logo: ...
(Date:2/22/2017)... 22, 2017 Research and Markets has ... by Drug Molecule (Biologic, Small Molecule Drugs), By Route of ... Blockers) Outlook 2022" report to their offering. ... The global psoriasis ... 2016-2022 This report provides a detailed analysis of ...
(Date:2/22/2017)... LONDON , Feb. 22, 2017  Based ... therapy market, Frost & Sullivan recognizes SnooZeal, Inc. ... SnooZeal is a highly innovative product that intelligently ... training the tongue muscles through the clinically proven ... over-the-counter (OTC) status, SnooZeal is one of the ...
Breaking Medicine Technology:
(Date:2/22/2017)... WV (PRWEB) , ... February 22, 2017 , ... ... awarded a contract to Quality Insights to help small practices in Delaware, New ... Payment Program, established by the Medicare Access and CHIP Reauthorization Act of 2015 ...
(Date:2/22/2017)... ... 22, 2017 , ... A product of digesting a micronutrient found in soy ... from eating soy foods, while others do not, a University of Pittsburgh Graduate School ... equol—a substance made by some types of “good” gut bacteria when they metabolize isoflavones ...
(Date:2/22/2017)... CT (PRWEB) , ... February 22, 2017 , ... The ... and the 2017 Forecast —on Thursday, February 23, 2017, at 1:00 PM ET. A ... webinar is part of the Interactive Webinar Series. , If you want to find ...
(Date:2/22/2017)... NY (PRWEB) , ... February 22, 2017 , ... Social ... — especially for hospitals and health systems. Smith & Jones’ delves into this insight ... this episode, President of Smith & Jones David Vener meets up with social media ...
(Date:2/22/2017)... , ... February 22, 2017 , ... ... Yet with so many different solutions on the market, it is easy to ... Texas Premier Locksmith offers a complimentary security consultation. , Home Security ...
Breaking Medicine News(10 mins):